Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


Articles published in Pediatr Infect Dis J

Retrieve available abstracts of 112 articles:
HTML format
Text format



Single Articles


    March 2017
  1. GOUVEIA M, Fiorentino F, Jesus G, Costa J, et al
    Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Portugal.
    Pediatr Infect Dis J. 2017 Mar 10. doi: 10.1097/INF.0000000000001587.
    PubMed     Text format     Abstract available


    February 2017
  2. SEDERDAHL BK, Yi J, Jerris R, Gillespie SE, et al
    The Residual Vaccine-Preventable Burden of Rotavirus Disease.
    Pediatr Infect Dis J. 2017 Feb 15. doi: 10.1097/INF.0000000000001580.
    PubMed     Text format     Abstract available


  3. LIVNI G, Wainstein A, Birk E, Chodick G, et al
    Influenza Vaccination Rate and Reasons for Non-Vaccination in Children with Cardiac Disease.
    Pediatr Infect Dis J. 2017 Feb 13. doi: 10.1097/INF.0000000000001579.
    PubMed     Text format     Abstract available


  4. CHRISTELLE TX, Min CS, Lee LY, Ong C, et al
    Serologic Responses After Hepatitis B Vaccination in Preterm Infants Born to Hepatitis B Surface Antigen Positive Mothers: Singapore Experience.
    Pediatr Infect Dis J. 2017 Feb 13. doi: 10.1097/INF.0000000000001578.
    PubMed     Text format     Abstract available


  5. LE MARECHAL M, Agrinier N, Fressard L, Verger P, et al
    Low Uptake of Meningococcal C Vaccination in France: A Cross-Sectional Nationwide Survey of General Practitioners' Perceptions, Attitudes and Practices.
    Pediatr Infect Dis J. 2017 Feb 3. doi: 10.1097/INF.0000000000001553.
    PubMed     Text format     Abstract available


    January 2017
  6. MARTINON-TORRES F, Dionne M, Greenberg D, Varman M, et al
    Safety, Tolerability, and Immunogenicity of Pentavalent Rotavirus Vaccine Manufactured by a Modified Process.
    Pediatr Infect Dis J. 2017 Jan 27. doi: 10.1097/INF.0000000000001511.
    PubMed     Text format     Abstract available


  7. PINTO M, Dawar M, Krajden M, Naus M, et al
    Will Infant Hepatitis B Vaccination Protect into Adulthood? Extended Canadian Experience After a 2, 4, 6 Month Immunization Schedule.
    Pediatr Infect Dis J. 2017 Jan 26. doi: 10.1097/INF.0000000000001543.
    PubMed     Text format     Abstract available


  8. CHUN CHAU JP, Lo SH, Chow Choi K, Kin Chau MH, et al
    Factors Determining the Uptake of Influenza Vaccination Among Children with Chronic Conditions.
    Pediatr Infect Dis J. 2017 Jan 19. doi: 10.1097/INF.0000000000001550.
    PubMed     Text format     Abstract available


  9. KUROSKY SK, Davis KL, Galindo CM
    Effect of Combination Vaccines on Hepatitis B Vaccine Compliance in Children in the United States.
    Pediatr Infect Dis J. 2017 Jan 17. doi: 10.1097/INF.0000000000001548.
    PubMed     Text format     Abstract available


  10. RODRIGUEZ MELO FI, Morales JJ, De Los Santos AH, Rivas E, et al
    Immunogenicity and Safety of a Booster Injection of DTap-IPV//Hib (Pentaxim(R)) Administered Concomitantly with Tetravalent Dengue Vaccine in Healthy Toddlers Aged 15 to 18 Months in Mexico: A Randomized Trial.
    Pediatr Infect Dis J. 2017 Jan 6. doi: 10.1097/INF.0000000000001542.
    PubMed     Text format     Abstract available


  11. LI F, Hu Y, Zhou Y, Chen L, et al
    A Randomized Controlled Trial to Evaluate a Potential Hepatitis B Booster Vaccination Strategy Using Combined Hepatitis A and B Vaccine.
    Pediatr Infect Dis J. 2017 Jan 3. doi: 10.1097/INF.0000000000001535.
    PubMed     Text format     Abstract available


    December 2016
  12. KOSALARAKSA P, Watanaveeradej V, Pancharoen C, Capeding MR, et al
    Long-Term Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers and Booster Response 5 Years After Primary Immunization.
    Pediatr Infect Dis J. 2016 Dec 27. doi: 10.1097/INF.0000000000001494.
    PubMed     Text format     Abstract available


  13. SIRIMA SB, Tiono A, Gansane Z, Siribie M, et al
    Immunogenicity and Safety Of 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Administered to Children with Sickle Cell Disease Between 8 Weeks and 2 Years of Age: A Phase III, Open, Controlled Study.
    Pediatr Infect Dis J. 2016 Dec 27. doi: 10.1097/INF.0000000000001518.
    PubMed     Text format     Abstract available


  14. DE WALS P, Zhou Z
    Cost-Effectiveness Comparison of Monovalent C Versus Quadrivalent ACWY Meningococcal Conjugate Vaccination in Canada.
    Pediatr Infect Dis J. 2016 Dec 23. doi: 10.1097/INF.0000000000001512.
    PubMed     Text format     Abstract available


  15. TRUCK J, Mitchell R, Jawad S, Clutterbuck EA, et al
    Divergent Memory B Cell Responses in a Mixed Infant Pneumococcal Conjugate Vaccine Schedule.
    Pediatr Infect Dis J. 2016 Dec 23. doi: 10.1097/INF.0000000000001497.
    PubMed     Text format     Abstract available


  16. MERINO ARRIBAS JM, Carmona Martinez A, Horn M, Porcuna XM, et al
    Safety and Immunogenicity of the Quadrivalent Meningococcal Serogroups A, C, W and Y Tetanus Toxoid Conjugate Vaccine Co-Administered with Routine Childhood Vaccines in European Infants: An Open, Randomized Trial.
    Pediatr Infect Dis J. 2016 Dec 19. doi: 10.1097/INF.0000000000001484.
    PubMed     Text format     Abstract available


  17. MARCHISIO P, Esposito S, Picca M, Baggi E, et al
    Serotypes not Included in 13-Valent Pneumococcal Vaccine as Causes of Acute Otitis Media with Spontaneous Tympanic Membrane Perforation in a Geographic Area with High Vaccination Coverage.
    Pediatr Infect Dis J. 2016 Dec 15. doi: 10.1097/INF.0000000000001485.
    PubMed     Text format     Abstract available


  18. BECKER-DREPS S, Vilchez S, Bucardo F, Twitchell E, et al
    The Association Between Fecal Biomarkers of Environmental Enteropathy and Rotavirus Vaccine Response in Nicaraguan Infants.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  19. LEE AM, Burns JC, Tremoulet AH
    Safety of Infliximab Following Live Virus Vaccination in Kawasaki Disease Patients.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


    November 2016
  20. MARTINON-TORRES F, Wysocki J, Center KJ, Czajka H, et al
    Circulating Antibody 1 and 2 Years After Vaccination With the 13-Valent Pneumococcal Conjugate Vaccine in Preterm Compared with Term Infants.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  21. ZHANG L, Yang P, Thompson MG, Pan Y, et al
    Influenza Vaccine Effectiveness in Preventing Influenza Illness Among Children During School-Based Outbreaks in the 2014-2015 Season in Beijing, China.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  22. MAROM T, Peretz SB, Schwartz O, Goldfarb A, et al
    Impact of Pneumococcal Conjugate Vaccines on Selected Head and Neck Infections in Hospitalized Israeli Children.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  23. HARRIS SL, Donald RG, Hawkins JC, Tan C, et al
    Neisseria meningitidis Serogroup B Vaccine, Bivalent rLP2086, Induces Broad Serum Bactericidal Activity Against Diverse Invasive Disease Strains Including Outbreak Strains.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  24. SRICHAROENCHAI S, Lapphra K, Chuenkitmongkol S, Phongsamart W, et al
    Immunogenicity of a Live Attenuated Chimeric Japanese Encephalitis Vaccine as a Booster Dose After Primary Vaccination with Live Attenuated SA14-14-2 Vaccine: A Phase IV Study in Thai Children.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  25. BLOCK SL, Klein NP, Sarpong K, Russell S, et al
    Lot-to-Lot Consistency, Safety, Tolerability, and Immunogenicity of an Investigational Hexavalent Vaccine in US Infants.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  26. VESIKARI T, Becker T, Vertruyen AF, Poschet K, et al
    A Phase III Randomized, Double-Blind, Clinical Trial of an Investigational Hexavalent Vaccine Given at 2, 3, 4, and 12 Months.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  27. AABY P, Ravn H, Benn CS
    The WHO Review of the Possible Nonspecific Effects of Diphtheria-Tetanus-Pertussis Vaccine.
    Pediatr Infect Dis J. 2016;35:1247-1257.
    PubMed     Text format     Abstract available


  28. MO X, Gai Tobe R, Liu X, Mori R, et al
    Cost-effectiveness and Health Benefits of Pediatric 23-valent Pneumococcal Polysaccharide Vaccine, 7-valent Pneumococcal Conjugate Vaccine and Forecasting 13-valent Pneumococcal Conjugate Vaccine in China.
    Pediatr Infect Dis J. 2016;35:e353-e361.
    PubMed     Text format     Abstract available


  29. BETTINGER JA, Vanderkooi OG, Scheifele DW, Halperin SA, et al
    Do Dose Numbers Matter?: Evaluation of Differing Infant and Toddler Meningococcal C Conjugate Vaccine Programs in Canadian Children.
    Pediatr Infect Dis J. 2016;35:1242-1246.
    PubMed     Text format     Abstract available


  30. AABY P, Ravn H, Benn CS, Rodrigues A, et al
    Randomized Trials Comparing Inactivated Vaccine After Medium- or High-titer Measles Vaccine With Standard Titer Measles Vaccine After Inactivated Vaccine: A Meta-analysis.
    Pediatr Infect Dis J. 2016;35:1232-1241.
    PubMed     Text format     Abstract available


  31. SMEDEGAARD LM, Poulsen A, Kristensen IA, Rosthoj S, et al
    Varicella Vaccination of Children With Leukemia Without Interruption of Maintenance Therapy: A Danish Experience.
    Pediatr Infect Dis J. 2016;35:e348-e352.
    PubMed     Text format     Abstract available


  32. ARYA BK, Bhattacharya SD, Sutcliffe CG, Kumar Niyogi S, et al
    Impact of Haemophilus influenzae Type B Conjugate Vaccines on Nasopharyngeal Carriage in HIV-infected Children and Their Parents From West Bengal, India.
    Pediatr Infect Dis J. 2016;35:e339-e347.
    PubMed     Text format     Abstract available


    October 2016
  33. SATTER S, Gastanaduy P, Islam K, Rahman M, et al
    Hospital-Based Surveillance for Rotavirus Gastroenteritis among Young Children in Bangladesh: Defining the Potential Impact of a Rotavirus Vaccine Program.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  34. GRUBER JF, Hille DA, Liu GF, Kaplan SS, et al
    Heterogeneity of Rotavirus Vaccine Efficacy among Infants in Developing Countries.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  35. MAMMEN VG, Dangor Z, Moore DP, Izu A, et al
    Hospitalization for Culture-Confirmed Pulmonary Tuberculosis in the Era of Childhood Pneumococcal Conjugate Vaccine Immunization.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  36. VESIKARI T, Silfverdal SA, Jordanov E, Feroldi E, et al
    A Randomized, Controlled Study of DTaP-IPV-HB-PRP-T, a Fully Liquid Hexavalent Vaccine, Administered in a 3, 5 and 11-12 Month Schedule.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  37. ZHU F, Deckx H, Roten R, Michiels B, et al
    Comparative Efficacy, Safety and Immunogenicity of Hepavax-Gene(R) TF and Engerix-B(R) Recombinant Hepatitis B Vaccines in Neonates in China.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  38. STRENG A, Grote V, Rack-Hoch A, Liese JG, et al
    Decline of Neurologic Varicella Complications in Children During the First 7 Years After Introduction of Universal Varicella Vaccination in Germany, 2005-2011.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  39. CIVEN R, Marin M, Zhang J, Abraham A, et al
    Update on Incidence of Herpes Zoster Among Children and Adolescents After Implementation of Varicella Vaccination, Antelope Valley, CA, 2000 to 2010.
    Pediatr Infect Dis J. 2016;35:1132-6.
    PubMed     Text format     Abstract available


    September 2016
  40. TOLEDO ME, Casanova MF, Linares-Perez N, Garcia-Rivera D, et al
    Prevalence of Pneumococcal Nasopharyngeal Carriage Among Children 2-18 Months of Age: Baseline Study Pre-Introduction of Pneumococcal Vaccination in Cuba.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  41. URUENA A, Gonzalez JE, Rearte A, Carrega ME, et al
    Single-Dose Universal Hepatitis A Immunization in One Year Old Children in Argentina: High Prevalence of Protective Antibodies Up to 9 Years Following Vaccination.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  42. WU D, Yen C, Yin ZD, Li YX, et al
    The Public Health Burden of Rotavirus Disease in Children <5 Years of Age and Considerations for Rotavirus Vaccine Introduction in China.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  43. PHILIP RK, Shapiro M, Paterson P, Glismann S, et al
    Is It Time For Vaccination To "Go Viral"?
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


    August 2016
  44. KAUR R, Casey JR, Pichichero ME
    Emerging Streptococcus pneumoniae Strains Colonizing the Nasopharynx in Children After 13-valent Pneumococcal Conjugate Vaccination in Comparison to the 7-valent Era, 2006-2015.
    Pediatr Infect Dis J. 2016;35:901-6.
    PubMed     Text format     Abstract available


    July 2016
  45. HEMMING-HARLO M, Markkula J, Huhti L, Salminen M, et al
    Decrease of Rotavirus Gastroenteritis to a Low Level Without Resurgence for 5 Years After Universal RotaTeq(R) Vaccination in Finland.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  46. AABY P, Ravn H, Benn CS, Rodrigues A, et al
    Randomized Trials Comparing Inactivated Vaccine After Medium or High Titer Measles Vaccine with Standard Titer Measles Vaccine After Inactivated Vaccine: A Meta-Analysis.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  47. TAGARRO A, Bote P, Sanchez A, Otheo E, et al
    Complications of Pneumococcal Bacteremia After 13-Valent Conjugate Vaccine Withdrawal.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


    June 2016
  48. MO X, Tobe RG, Liu X, Mori R, et al
    Cost-Effectiveness and Health Benefits of Pediatric 23-Valent Pneumococcal Polysaccharide Vaccine, 7-Valent and Forecasting 13-Valent Pneumococcal Conjugate Vaccines in China.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  49. AABY P, Ravn H, Benn CS
    The WHO Review of the Possible Non-Specific Effects of Diphtheria-Tetanus-Pertussis Vaccine.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  50. REGAN AK, de Klerk N, Moore HC, Omer SB, et al
    Effect of Maternal Influenza Vaccination on Hospitalization for Respiratory Infections in Newborns: A Retrospective Cohort Study.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  51. BETTINGER JA, Vanderkooi OG, Scheifele DW, Halperin SA, et al
    Do Dose Numbers Matter? Evaluation of Differing Infant and Toddler Meningococcal C Conjugate Vaccine Programs in Canadian Children.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  52. KITTIKRAISAK W, Suntarattiwong P, Ditsungnoen D, Klungthong C, et al
    Effectiveness of the 2013 and 2014 Southern Hemisphere Influenza Vaccines Against Laboratory-Confirmed Influenza in Young Children Using a Test-Negative Design, Bangkok, Thailand.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  53. WAGNER AL, Sun X, Huang Z, Ren J, et al
    On-Time Measles and Pneumococcal Vaccination of Shanghai Children: The Impact of Individual- and Neighborhood-Level Factors.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  54. SMEDEGAARD LM, Poulsen A, Kristensen IA, Rosthoj S, et al
    Varicella Vaccination of Children with Leukemia without Interruption of Maintenance Therapy - A Danish Experience.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  55. ARYA BK, Bhattacharya SD, Sutcliffe C, Niyogi SK, et al
    Impact of Haemophilus influenzae Type b Conjugate Vaccines (HibCV) on Nasopharyngeal Carriage in HIV Infected Children and Their Parents from West Bengal, India.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  56. OLBRICH P, Falcon-Neyra L, Molinos-Quintana A, Aguero-Sanchez M, et al
    First Documented Case of Influenza A (H3N2 Subtype) Infection in a Patient With Complete Interferon Gamma Receptor 1 Deficiency: A Call for Systemic Vaccination Strategies.
    Pediatr Infect Dis J. 2016;35:712-3.
    PubMed     Text format    


    May 2016
  57. KUTER BJ, Brown M, Wiedmann RT, Hartzel J, et al
    Safety and Immunogenicity of M-M-R(R)II (Combination Measles-Mumps-Rubella Vaccine) in Clinical Trials of Healthy Children Conducted Between 1988 and 2009.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  58. LOPEZ P, Lanata CF, Zambrano B, Cortes M, et al
    Immunogenicity and Safety of Yellow Fever Vaccine (Stamaril(R)) when Administered Concomitantly with a Tetravalent Dengue Vaccine Candidate in Healthy Toddlers at 12-13 Months of Age in Colombia and Peru: A Randomized Trial.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  59. LAMBERTI LM, Ashraf S, Walker CL, Black RE, et al
    A Systematic Review of the Effect of Rotavirus Vaccination on Diarrhea Outcomes Among Children Younger Than 5 Years.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  60. ZHU F, Hu Y, Li J, Ye Q, et al
    Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine Compared With 7-Valent Pneumococcal Conjugate Vaccine Among Healthy Infants in China.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  61. FINN A, Morales-Aza B, Sikora P, Giles J, et al
    Density Distribution of Pharyngeal Carriage of Meningococcus in Healthy Young Adults: New Approaches to Studying the Epidemiology of Colonization and Vaccine Indirect Effects.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  62. SHRIVASTWA N, Gillespie BW, Lepkowski JM, Boulton ML, et al
    Vaccination Timeliness in Children under India's Universal Immunization Program.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  63. DITKOWSKY J, Kohlhoff S, Smith-Norowitz TA
    The Cost-Effectiveness of Varicella Zoster Virus Vaccination Considering Late Onset Asthma.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  64. GRANT LR, Hammitt LL, O'Brien SE, Jacobs MR, et al
    Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage Among American Indians.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  65. WOO EJ, Winiecki SK, Arya D, Beeler J, et al
    Adverse Events After MMR or MMRV Vaccine in Infants Under 9 Months Old.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  66. WATANABE T
    Transient Takayasu Arteritis After Influenza Vaccinations.
    Pediatr Infect Dis J. 2016;35:596-7.
    PubMed     Text format    


  67. POYHONEN L, Pauniaho SL, Kroger L, Korppi M, et al
    Orthopedic Complications in Former Bacillus Calmette-Guerin Osteitis Patients.
    Pediatr Infect Dis J. 2016;35:579-80.
    PubMed     Text format     Abstract available


  68. GAENSBAUER JT, Asturias EJ, Soto M, Holt E, et al
    Pediatric Invasive Pneumococcal Disease in Guatemala City: Importance of Serotype 2.
    Pediatr Infect Dis J. 2016;35:e139-43.
    PubMed     Text format     Abstract available


    April 2016
  69. VAN DEN BERGH MR, Spijkerman J, Francois N, Swinnen K, et al
    Immunogenicity, Safety, and Reactogenicity of a Booster Dose of the 10-Valent Pneumococcal Nontypeable H. influenzae Protein D Conjugate Vaccine (PHiD-CV) Co-Administered with DTPa-IPV-Hib in Dutch Children: A Randomized Controlled Trial.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  70. DAGAN R, Ashkenazi S, Livni G, Go O, et al
    Long-Term Serologic Follow-Up of Children Vaccinated with a Pediatric Formulation of Virosomal Hepatitis A Vaccine Administered with Routine Childhood Vaccines at 12-15 Month of Age.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  71. SHAH MP, Tate JE, Steiner CA, Parashar UD, et al
    Decline in Emergency Department Visits for Acute Gastroenteritis among Children in 10 US States Following Implementation of Rotavirus Vaccination, 2003-2013.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  72. TRUCK J, Jawad S, Goldblatt D, Roalfe L, et al
    The Antibody Response Following a Booster with Either a 10- Or 13-Valent Pneumococcal Conjugate Vaccine in Toddlers Primed with a 13-Valent Pneumococcal Conjugate Vaccine in Early Infancy.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  73. SU WJ, Lo HY, Chang CH, Chang LY, et al
    Effectiveness of Pneumococcal Conjugate Vaccines of Different Valences Against Invasive Pneumococcal Disease Among Children in Taiwan: A Nationwide Study.
    Pediatr Infect Dis J. 2016;35:e124-33.
    PubMed     Text format     Abstract available


  74. HANKE CR, Grijalva CG, Chochua S, Pletz MW, et al
    Bacterial Density, Serotype Distribution and Antibiotic Resistance of Pneumococcal Strains from the Nasopharynx of Peruvian Children Before and After Pneumococcal Conjugate Vaccine 7.
    Pediatr Infect Dis J. 2016;35:432-9.
    PubMed     Text format     Abstract available


  75. BRUUN T, Salamanca BV, Bekkevold T, Vainio K, et al
    Burden of Rotavirus Disease in Norway: Using National Registries for Public Health Research.
    Pediatr Infect Dis J. 2016;35:396-400.
    PubMed     Text format     Abstract available


  76. ALMEIDA AF, Flor-de-Lima F, Simoes JS, Castro C, et al
    Pertussis in a Portuguese Pediatric Tertiary Care Hospital.
    Pediatr Infect Dis J. 2016;35:466-7.
    PubMed     Text format    


  77. SHIN M, Salamanca BV, Kristiansen IS, Flem E, et al
    Healthcare Costs of Rotavirus and Other Types of Gastroenteritis in Children in Norway.
    Pediatr Infect Dis J. 2016;35:e97-e101.
    PubMed     Text format     Abstract available


    March 2016
  78. COSTA I, Linhares AC, Cunha MH, Tuboi S, et al
    Sustained Decrease in Gastroenteritis-Related Deaths and Hospitalizations in Children <5of Age Years After the Introduction of Rotavirus Vaccination: A Time-Trend Analysis in Brazil (2001-2010).
    Pediatr Infect Dis J. 2016.
    PubMed     Text format    


  79. MUSE D, Christensen S, Bhuyan P, Absalon J, et al
    A Phase 2, Randomized, Active-controlled, Observer-blinded Study to Assess the Immunogenicity, Tolerability, and Safety of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered With Tetanus, Diphtheria and Acellular Pertussis Vaccine a
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  80. MACDONALD SE, Bell CA, Simmonds KA
    Coverage and Determinants of Uptake for Privately Funded Rotavirus Vaccine in a Canadian Birth Cohort, 2008-2013.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  81. POYHONEN L, Kroger L, Huhtala H, Makinen J, et al
    Interferon-Gamma-Dependent Immunity in Bacillus Calmette- Guerin Vaccine Osteitis Survivors.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  82. ANDRADEA DC, Borges IC, Adrian PV, Meinke A, et al
    Effect of Pneumococcal Conjugate Vaccine on the Natural Antibodies and Antibody Responses Against Protein Antigens from Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Children with Community-Acquired Pneumonia.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


    February 2016
  83. KLEIN NP, Baine Y, Kolhe D, Baccarini CI, et al
    Five-Year Antibody Persistence and Booster Response Following One or Two Doses of Meningococcal A, C, W, and Y Tetanus Toxoid Conjugate Vaccine in Healthy Children.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  84. DOLL MK, Gagneur A, Tapiero B, Charest H, et al
    Temporal Changes in Pediatric Gastroenteritis Following Rotavirus Vaccination in Quebec.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  85. SETSE RW, Siberry GK, Moss WJ, Wheeling J, et al
    Meningococcal Conjugate and tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccination Among HIV-Infected Youth.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  86. SENDERS S, Bhuyan P, Jiang Q, Absalon J, et al
    Immunogenicity, Tolerability, and Safety in Adolescents of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered with Quadrivalent Human Papilloma Virus Vaccine.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  87. CURRAN D, Terlinden A, Poirrier JE, Masseria C, et al
    Vaccine Timeliness: A Cost Analysis of the Potential Implications of Delayed Pertussis Vaccination in the US.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


    January 2016
  88. SNAPE MD, Voysey M, Biostat M, Finn A, et al
    Persistence of Bactericidal Antibodies Following Infant Serogroup B Meningococcal Immunization and Booster Dose Response at 12, 18 or 24 Months of Age.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  89. PELLMAN H, Brown B
    Parental Reasons for Acceptance or Refusal of Human Papillomavirus Vaccine in a Southern California Pediatric Practice.
    Pediatr Infect Dis J. 2016;35:119-120.
    PubMed     Text format    


    December 2015
  90. WEINMANN S, Vandermeer M, Roberts M, Mullooly J, et al
    Positive Predictive Value of ICD-9 Code for Herpes Zoster Among Children During the Varicella Vaccine Era.
    Pediatr Infect Dis J. 2015.
    PubMed     Text format     Abstract available


  91. KATZ MA, Lebo E, Emukule GO, Otieno N, et al
    Uptake and Effectiveness of a Trivalent Inactivated Influenza Vaccine in Children in Urban and Rural Kenya, 2010-2012.
    Pediatr Infect Dis J. 2015.
    PubMed     Text format     Abstract available


  92. MORAGA-LLOP F, Garcia-Garcia JJ, Diaz-Conradi A, Ciruela P, et al
    Vaccine Failures in Patients Properly Vaccinated with 13-Valent Pneumococcal Conjugate Vaccine in Catalonia, a Region with Low Vaccination Coverage.
    Pediatr Infect Dis J. 2015.
    PubMed     Text format     Abstract available


  93. SAHA SK, Hossain B, Islam M, Hasanuzzaman M, et al
    Epidemiology of Invasive Pneumococcal Disease in Bangladeshi Children Before Introduction of Pneumococcal Conjugate Vaccine.
    Pediatr Infect Dis J. 2015.
    PubMed     Text format     Abstract available


  94. SMIT MA, Wang HL, Kim E, Barragan N, et al
    Influenza Vaccine is Protective Against Laboratory-Confirmed Influenza in Obese Children.
    Pediatr Infect Dis J. 2015.
    PubMed     Text format     Abstract available


  95. THOMPSON MG, Clippard J, Petrie JG, Jackson ML, et al
    Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 months to 8 Years Old during 2011-2012 and 2012-2013: The Importance of Two Priming Doses.
    Pediatr Infect Dis J. 2015.
    PubMed     Text format     Abstract available


  96. BLYTH CC, Jacoby P, Effler PV, Kelly H, et al
    Influenza Vaccine Effectiveness and Uptake in Children at Risk of Severe Disease.
    Pediatr Infect Dis J. 2015.
    PubMed     Text format     Abstract available


  97. VESIKARI T, Forsten A, Bianco V, Van der Wielen M, et al
    Immunogenicity, Safety and Antibody Persistence of a Booster Dose of Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine Compared with Monovalent Meningococcal Serogroup C Vaccine Administered Four Years After Primary Vaccination Using th
    Pediatr Infect Dis J. 2015;34:e298-307.
    PubMed     Text format     Abstract available


  98. SIGURDSSON S, Kristinsson KG, Erlendsdottir H, Hrafnkelsson B, et al
    Decreased Incidence of Respiratory Infections in Children After Vaccination with Ten-valent Pneumococcal Vaccine.
    Pediatr Infect Dis J. 2015;34:1385-90.
    PubMed     Text format     Abstract available


    November 2015
  99. BERG AS, Inchley C, Aase A, Fjaerli HO, et al
    Etiology of Pneumonia in a Pediatric Population with High Pneumococcal Vaccine Coverage. A Prospective Study.
    Pediatr Infect Dis J. 2015.
    PubMed     Text format     Abstract available


  100. LYU S, Yao KH, Dong F, Xu BP, et al
    Vaccine Serotypes of Streptococcus pneumoniae with High-Level Antibiotic Resistance Isolated More Frequently 7 Years After the Licensure of PCV7 in Beijing.
    Pediatr Infect Dis J. 2015.
    PubMed     Text format     Abstract available


  101. KOUTOUZIS EI, Michos A, Koutouzi FI, Chatzichristou P, et al
    Pneumococcal Mastoiditis in Children Before and After the Introduction of Conjugate Pneumococcal Vaccines.
    Pediatr Infect Dis J. 2015.
    PubMed     Text format     Abstract available


  102. HUMMEL IB, Huber B, Wenzel JJ, Jilg W, et al
    Markers of Protection in Children and Adolescents 6-14 Years After Primary Hepatitis B Vaccination in Real-Life - A Pilot Study.
    Pediatr Infect Dis J. 2015.
    PubMed     Text format     Abstract available


  103. TOMIANOVIC D, Bauwens J, Heininger U, Bonhoeffer J, et al
    Global vaccine safety assessment: challenges and opportunities.
    Pediatr Infect Dis J. 2015.
    PubMed     Text format    


  104. IZURIETA P, Uy-Aragon MJ, Drame M, Vaughn DW, et al
    Assessment of Prime-Boost Vaccination using an AS03B-Adjuvanted Influenza A(H5N1) Vaccine: A Randomized Trial in Children 3 to less Than 18 Years of Age.
    Pediatr Infect Dis J. 2015.
    PubMed     Text format     Abstract available


  105. KIM DS, Jang GC, Cha SH, Choi SH, et al
    Immunogenicity and Safety of a Booster Dose of a Live Attenuated Japanese Encephalitis Chimeric Vaccine Given 1 Year After Primary Immunization in Healthy Children in the Republic of Korea.
    Pediatr Infect Dis J. 2015.
    PubMed     Text format     Abstract available


    October 2015
  106. ESTRADA J, Najera M, Pounds N, Catano G, et al
    Clinical and Serologic Response to the 23-Valent Polysaccharide Pneumococcal Vaccine in Children and Teens with Recurrent Upper Respiratory Tract Infections and Selective Antibody Deficiency.
    Pediatr Infect Dis J. 2015.
    PubMed     Text format     Abstract available


  107. GRADOUX E, Asner S, Perez MH, Crisinel PA, et al
    An Invasive Pneumococcal Infection Due to Streptococcus pneumoniae Serotype 24.
    Pediatr Infect Dis J. 2015;34:1142.
    PubMed     Text format    


    June 2015
  108. WENDORF KA, Kay M, Ortega-Sanchez IR, Munn M, et al
    Cost of measles containment in an ambulatory pediatric clinic.
    Pediatr Infect Dis J. 2015;34:589-93.
    PubMed     Text format     Abstract available


    April 2015
  109. MOLYNEUX E, Njiram'madzi J
    Prevention and treatment of bacterial meningitis in resource poor settings.
    Pediatr Infect Dis J. 2015;34:441-3.
    PubMed     Text format    


    March 2015
  110. MAYANSKIY N, Alyabieva N, Ponomarenko O, Pakhomov A, et al
    Bacterial etiology of acute otitis media and characterization of pneumococcal serotypes and genotypes among children in Moscow, Russia.
    Pediatr Infect Dis J. 2015;34:255-60.
    PubMed     Text format     Abstract available


    July 2014
  111. HEALY CM, Rench MA, Wootton SH, Castagnini LA, et al
    Evaluation of the Impact of a Pertussis Cocooning Program on Infant Pertussis Infection.
    Pediatr Infect Dis J. 2014.
    PubMed     Text format     Abstract available


  112. VON MOLLENDORF C, Cohen C, de Gouveia L, Naidoo N, et al
    Risk Factors for Invasive Pneumococcal Disease among Children less Than 5 Years of Age in a High HIV-Prevalence Setting, South Africa, 2010 to 2012.
    Pediatr Infect Dis J. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: